Last week, we welcomed Mark Melton, MSc to our team! As the founder of ClearPath Biomarker Ops, Mark brings a wealth of expertise to Slope and will be essential in helping our team develop the first-ever end-to-end solution for #clinicaltrialexecution. We were able to sit down with him this week and discuss his previous experience in the #clinicaltrials industry, what he thinks the biggest challenges in #clinicalresearch are, and where he sees this next chapter leading for Slope. #clinicalinnovation
Slope’s Post
More Relevant Posts
-
✅ Aliquoting fake blood into cryovials ✅ Running mock sample management exercises using lab manuals ✅ Experiencing a day-in-the-life at a busy research site These are just a few of the experiences our CEO, Rust Felix, and other members of the Slope team had during their recent visit at UPMC Hillman Cancer Center. A huge thank you to the UPMC team for providing us with a new perspective on the frontline of #ClinicalResearch.
CEO + Co-founder of Slope | Biospecimen Lifecycle Software (B2B SaaS), Data, and Services for Clinical Trials
As someone deeply invested in transforming the inefficiencies of clinical research, I can't stress enough how valuable it is to spend a full day at a site — not just to shake hands, but to truly immerse yourself in the work. Roll up your sleeves, follow their SOPs, and I guarantee it will fundamentally change your perspective. Last week Jim Munz, Alexander Yant, Ross Cooper, and I visited UPMC Hillman Cancer Center — one of only three NCI-designated cancer centers in Pennsylvania — where they are supporting hundreds of active studies each year across 12 disease centers. We experienced firsthand the rigor and precision that underpins each phase of the biospecimen lifecycle through a mock sample management exercise. Over several hours we worked alongside the UPMC CRS lab team to process, store, and pack patient samples, navigating the same poorly constructed lab manuals the lab team must contend with each day. Even as someone who has talked to countless sites over the years, the in-person, hands-on experience was eye-opening. It reaffirmed just how vital these steps are to the success of clinical trials and, ultimately, how complex these workflows can become. At Slope, we are committed to transforming biospecimens into breakthroughs, and visits like this help us stay closely connected to the frontline of clinical research. A tremendously big thank you to Jamie Voyten and her team for hosting us, teaching me how to aliquot fake blood into cryovials, and for providing invaluable insights into how we can continue to support the important work of research sites like UPMC Hillman. Your dedication is inspiring!
-
-
Are you heading to OCT New England this month? Our team members, Jack Bradley and Charlie Zogzas, PhD will be there! Don't miss the opportunity to meet with them and learn more about our end-to-end approach to everything from kit inventory to sample management — streamlining your processes and centralizing crucial metadata in one place. Reach out to Jack or Charlie via DM to schedule a meeting! #OCTNE2024 #OutsourcingClinicalTrials #ClinicalResearch
-
-
Last month, we welcomed Amanda Schreiber to our Biospecimen Data and Operations team. This week on the blog, we had the pleasure of sitting down with her to dive deep into the world of biospecimen management—from research site compliance to sample tracking and data reconciliation. Read below to learn more about what she's discovered from years of working in various capacities with sponsors, research sites, labs, CROs, and other vendors! #ClinicalResearch #ClinicalTrials #BiospecimenOperations
What Are The Most Prevalent Challenges around Biospecimen Data & Operations? A Q&A with Slope’s Mandy Schreiber · Slope Blog
slopeclinical.com
-
Are you attending #ResearchRevolution next week? Be sure to catch our very own Ethan Seville as he participates in an insightful panel discussion focused on #clinicaltrial sustainability on Monday at 1:10pm. This session is sure to be one you don't want to miss as the panelists offer their perspectives on how the industry can evolve toward more sustainable practices. #RR24 #clinicaltrialsustainability #clinicalresearch
Back in my research coordinator days, I regularly had to destroy massive amounts of unused kits, IP, and other clinical supply. I'm not alone in this either- chronic oversupply seriously impacts practically every other coordinator I've met. At #RR24, Kunal Sampat, Aaron Meadows, Natasha Wilson and I will take a deep dive into the serious impact a lack of sustainable practices has on clinical trials. We'll also share real world strategies to avoid throwing study budgets in the dumpster. Come join us!
-
-
Join us next week for this product demo to discover how we're optimizing the entire biospecimen lifecycle by replacing traditional manual practices with automated sample tracking, guided workflows for sites, digital requisition forms, and more. In this 30-minute session, we'll cover how our Biospecimen360™ software can: ✅ Control & Standardize Sample Metadata Capture ✅ Improve Site Efficiency & Compliance ✅ Provide Access to High-Quality, Reliable Data #ClinicalResearch #ClinicalTrials #BiospecimenManagement
This content isn’t available here
Access this content and more in the LinkedIn app
-
Curious about the tech-enabled services we launched earlier this month? Now's your chance for an in-depth look! In our latest blog post, Slope's Vice President of Biospecimen Data and Operations, Mark Melton, gets into what inspired the development of these services, how they work, and the impact they’re expected to have on sponsors using them. #ClinicalResearch #ClinicalTrials #BiospecimenOperations #LabOperations #SampleTracking #BiospecimenData
What’s Behind Slope’s New Tech-Enabled Services? A Q&A with Slope’s VP of Biospecimen Data & Operations, Mark Melton · Slope Blog
slopeclinical.com
-
Today is the final day for pharmaceutical, biotech, and medical device professionals to participate in the Biospecimen Management Consortium (BMC)'s survey. In just 10 minutes, you can make a meaningful contribution to the future of clinical research by helping the BMC understand the current state of biospecimen management practices.
It’s official! The Biospecimen Management Consortium (BMC) has launched the 2024 Biospecimen Management Benchmarking Survey. This comprehensive survey provides valuable insights into the current landscape of biospecimen management, serving as the foundation for industry standards and best practices development. If you are a pharmaceutical, biotech, or medical device professional, don't miss your chance to contribute — this survey closes on September 20th. To receive access to the survey, please visit this link: https://hubs.la/Q02PHvcm0
-
-
The path from idea to medical breakthrough can be filled with complexities, challenges, and setbacks. Among the critical factors that influence study outcomes, biospecimen data and operations often play a pivotal role. In this week's blog, discover how having a knowledgeable guide with the right expertise in biospecimen operations, data, and sample management can make the difference between a successful trial and costly setbacks. #BiospecimenManagement #BiospecimenOperations #SampleManagement
Why Sponsors Need Expertise in Biospecimen Lifecycle Management to Bring Their Breakthroughs to Life · Slope Blog
slopeclinical.com
-
#SoftwareEngineers — this post is for you! We're hiring a Staff Software Engineer to lead the design, development, and optimization of our systems. Ideal candidates will have 10+ years of professional experience, a proven history of leading successful software projects, and exceptional strategic thinking skills. To learn more about the other qualifications for this role and to apply, please visit this link: https://hubs.la/Q02PTr6d0 #Hiring #SoftwareDevelopment #RemoteOpportunity #SoftwareEngineering
-
-
It’s official! The Biospecimen Management Consortium (BMC) has launched the 2024 Biospecimen Management Benchmarking Survey. This comprehensive survey provides valuable insights into the current landscape of biospecimen management, serving as the foundation for industry standards and best practices development. If you are a pharmaceutical, biotech, or medical device professional, don't miss your chance to contribute — this survey closes on September 20th. To receive access to the survey, please visit this link: https://hubs.la/Q02PHvcm0
-
